354 related articles for article (PubMed ID: 12210753)
21. Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment.
Chen TL
Bone; 2004 Jul; 35(1):83-95. PubMed ID: 15207744
[TBL] [Abstract][Full Text] [Related]
22. Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin.
Kodama T; Goto T; Miyazaki T; Takahashi T
Int J Oral Maxillofac Implants; 2008; 23(6):1013-9. PubMed ID: 19216269
[TBL] [Abstract][Full Text] [Related]
23. Drynariae Rhizoma promotes osteoblast differentiation and mineralization in MC3T3-E1 cells through regulation of bone morphogenetic protein-2, alkaline phosphatase, type I collagen and collagenase-1.
Jeong JC; Lee JW; Yoon CH; Kim HM; Kim CH
Toxicol In Vitro; 2004 Dec; 18(6):829-34. PubMed ID: 15465649
[TBL] [Abstract][Full Text] [Related]
24. Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis.
Srivastava K; Tyagi AM; Khan K; Dixit M; Lahiri S; Kumar A; Changkija B; Khan MP; Nagar GK; Yadav DK; Maurya R; Singh SP; Jain GK; Wahajuddin ; Trivedi R; Chattopadhyay N; Singh D
Phytomedicine; 2013 Apr; 20(6):470-80. PubMed ID: 23395215
[TBL] [Abstract][Full Text] [Related]
25. The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro.
Tim Yoon S; Su Kim K; Li J; Soo Park J; Akamaru T; Elmer WA; Hutton WC
Spine (Phila Pa 1976); 2003 Aug; 28(16):1773-80. PubMed ID: 12923462
[TBL] [Abstract][Full Text] [Related]
26. Mixing conditions for cell scaffolds affect the bone formation induced by bone engineering with human bone marrow stromal cells, beta-tricalcium phosphate granules, and rhBMP-2.
Uchida M; Agata H; Sagara H; Shinohara Y; Kagami H; Asahina I
J Biomed Mater Res A; 2009 Oct; 91(1):84-91. PubMed ID: 18767063
[TBL] [Abstract][Full Text] [Related]
27. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates.
Wikesjö UM; Huang YH; Xiropaidis AV; Sorensen RG; Rohrer MD; Prasad HS; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):992-1000. PubMed ID: 18976396
[TBL] [Abstract][Full Text] [Related]
28. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells.
Luu HH; Song WX; Luo X; Manning D; Luo J; Deng ZL; Sharff KA; Montag AG; Haydon RC; He TC
J Orthop Res; 2007 May; 25(5):665-77. PubMed ID: 17290432
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of porcine bone marrow stromal cells by hyaluronan, dexamethasone and rhBMP-2.
Zou X; Li H; Chen L; Baatrup A; Bünger C; Lind M
Biomaterials; 2004 Oct; 25(23):5375-85. PubMed ID: 15130722
[TBL] [Abstract][Full Text] [Related]
30. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2).
Kato M; Toyoda H; Namikawa T; Hoshino M; Terai H; Miyamoto S; Takaoka K
Biomaterials; 2006 Mar; 27(9):2035-41. PubMed ID: 16256191
[TBL] [Abstract][Full Text] [Related]
31. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations.
Wikesjö UM; Qahash M; Polimeni G; Susin C; Shanaman RH; Rohrer MD; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):1001-10. PubMed ID: 18976397
[TBL] [Abstract][Full Text] [Related]
32. Immunolocalization of vascular endothelial growth factor on intramuscular ectopic osteoinduction by bone morphogenetic protein-2.
Kakudo N; Kusumoto K; Wang YB; Iguchi Y; Ogawa Y
Life Sci; 2006 Oct; 79(19):1847-55. PubMed ID: 16857215
[TBL] [Abstract][Full Text] [Related]
33. Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study.
Arpornmaeklong P; Kochel M; Depprich R; Kübler NR; Würzler KK
Int J Oral Maxillofac Surg; 2004 Jan; 33(1):60-70. PubMed ID: 14690661
[TBL] [Abstract][Full Text] [Related]
34. Cell origin in experimental repair of cricoid cartilage defects treated with recombinant human bone morphogenetic protein-2.
Tcacencu I; Carlsöö B; Stierna P
Wound Repair Regen; 2005; 13(3):341-9. PubMed ID: 15953055
[TBL] [Abstract][Full Text] [Related]
35. Improvement of porous beta-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application.
Abarrategi A; Moreno-Vicente C; Ramos V; Aranaz I; Sanz Casado JV; López-Lacomba JL
Tissue Eng Part A; 2008 Aug; 14(8):1305-19. PubMed ID: 18491953
[TBL] [Abstract][Full Text] [Related]
36. Effect of recombinant human fibroblast growth factor-2 on intramuscular ectopic osteoinduction by recombinant human bone morphogenetic protein-2 in rats.
Kakudo N; Kusumoto K; Kuro A; Ogawa Y
Wound Repair Regen; 2006; 14(3):336-42. PubMed ID: 16808813
[TBL] [Abstract][Full Text] [Related]
37. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (Type II bone) in dogs.
Wikesjö UM; Xiropaidis AV; Qahash M; Lim WH; Sorensen RG; Rohrer MD; Wozney JM; Hall J
J Clin Periodontol; 2008 Nov; 35(11):985-91. PubMed ID: 18976395
[TBL] [Abstract][Full Text] [Related]
38. Growth of new bone guided by implants in a murine calvarial model.
Freilich M; M Patel C; Wei M; Shafer D; Schleier P; Hortschansky P; Kompali R; Kuhn L
Bone; 2008 Oct; 43(4):781-8. PubMed ID: 18589010
[TBL] [Abstract][Full Text] [Related]
39. [The experimental research of the rhBMP-2-induced apoptosis in human glioma cells].
Zhang X; Wu J; Jing J
Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):610-3. PubMed ID: 11798828
[TBL] [Abstract][Full Text] [Related]
40. [Preparation of rhBMP-2/BCB reconstituted bone xenograft and assay of its osteoinductivity].
Yuan Z; Ma P; Hu YY; Zhao GY; Lu R; Sun L; Li D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Mar; 16(2):79-82. PubMed ID: 11944525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
